Pharmacokinetics, a main actor in a many-sided approach to severe 5-FU toxicity prediction

Br J Clin Pharmacol. 2009 Jan;67(1):132-4. doi: 10.1111/j.1365-2125.2008.03307.x. Epub 2008 Nov 5.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / pharmacokinetics*
  • Dihydrouracil Dehydrogenase (NADP) / genetics
  • Dihydrouracil Dehydrogenase (NADP) / metabolism*
  • Fluorouracil / administration & dosage
  • Fluorouracil / pharmacokinetics*
  • Humans
  • Leukocytes, Mononuclear / enzymology
  • Neoplasms / drug therapy
  • Neoplasms / metabolism*

Substances

  • Antimetabolites, Antineoplastic
  • Dihydrouracil Dehydrogenase (NADP)
  • Fluorouracil